Investor Relations

Analyst Coverage

Ladenburg Thallmann
Matthew L. Kaplan
Joseph P. Schwartz
Millendo Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Millendo Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Millendo Therapeutics, Inc. or its management. Millendo Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.